Home » Topics » Regulatory

Regulatory
RSS

Update on Interferon Sciences' Alferon N Injection

May 13, 1997

Fujisawa's Prograf cleared by FDA for use in kidney transplantation

May 9, 1997

FDA approves Mylan's generic extended-release diltiazem

May 9, 1997

FDA clears generic antidepressant from Teva

May 7, 1997

ANDA filed for Biovail generic calcium channel blocker

May 7, 1997

Fosamax cleared as preventive medication in osteoporosis

May 7, 1997

SmithKline Beecham's Androderm now available as a single patch system

May 7, 1997

FDA clears generic version of SKB's Compazine

May 6, 1997

Alpharma's Oral Acyclovir Suspension launched in the U.S.

May 2, 1997

Nippon Kayaku reports neuritogenic effects for known compound

May 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...